SMG: Another Miss Puts Management's Ability In Question; Vol Spikes

 | Jun 14, 2012 03:18AM ET

The Scotts Miracle-Gro Company, (SMG), along with its subsidiaries, is engaged in the manufacturing, marketing and sale of lawn and garden care products, with products for professional horticulture as well. It operates in three segments: Global Consumer, Global Professional and Scotts LawnService.

Let’s start with the news that drove the stock down and vol up on open this morning with an eye on bad news that was released just a month ago that seems to fly in the face of this report. More on the older news later in the article.

Scotts Miracle-Gro Co. said it likely will not meet its expected sales growth target this year as demand for its lawn and garden care products has slowed following a fast start to the lawn care season.

The Marysville-based company has boosted sales by 3 percent at its “largest retail partners” through the first half of the year, short of the 6 percent to 8 percent increase it had expected this year. Scotts (NYSE:SMG) does not expect to meet its adjusted earnings per share target of $2.65 to $2.85 for 2012.

Scotts got out to a fast start during the second quarter, but “the gardening season, which traditionally peaks in mid- to late-May, has not met expectations,” the company said.

Scotts also expects its business in Europe to fall short amid economic uncertainty and poor weather. -- Source: Columbus Business First via Yahoo! Finance;

The disturbing part here is that the firm re-iterated the sales forecast for the year, and a month later this happened (they guided down). That’s an ugly black eye for management. In fact, it’s almost incomprehensible.

On 5-8-2012 we read: “The Marysville, Ohio-based company reiterated its sales and profit outlook for the year.” But today we read: “Scotts Miracle-Gro Co. said it likely will not meet its expected sales growth target this year.”

For the SMG shareholders, this should not sit well… very not well.

On the vol side, we can see the rise today. The chart is a little deceiving due to the scale. I’ve included the vol chart alone, below – just IV30™ over the last six months.